It was previously reported that although Alox5 is required for induction of CML by BCR-ABL, lack of Alox5 in hematopoietic stem cells in the absence of BCR-ABL did not result in any significant hematopoietic defects [29]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.